Tetrahydroquinoline derivatives

Details Tetrahydroquinoline derivatives Tetrahydroquinoline derivatives

2002-06-25

2011-11-15

Desai, Rita (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S159000, C546S168000, C546S171000, C544S106000, C544S336000, C514S311000

Reexamination Certificate

active

08058441

ABSTRACT:
The present invention relates to tetrahydroquinoline derivatives having general formula (I) or a pharmaceutically acceptable salt thereof, wherein R1is formyl, (1-6C)alkylcarbonyl or (1-6C)alkylsulfonyl; R2and R3are H or (1-4C)alkyl; R4is phenyl; R5is (1-4C)alkyl; Y—X is (CO)—O, (SO)2—O, NHC(O)—O, NHC(S)—O, OC(O)—O, bond-O, C(O)—NH, S(O)2—NH, NHC(O)—NH, NHC(S)—NH, OC(O)—NH, bond-NH, NH—C(O), O—C(O), NH—S(O)2, or O—S(O)2or Y—X is a bond; R6is H, trifluormethyl, (1-6C)alkyl, 1- or 2-adamantyl(1-4C)alkyl, (2-6C)alkenyl, (3-9C)heteroaryl, (3-6C)cycloalkyl, (2-6C)heterocycloalkyl, (1-4C)alkylthio(1-4C)alkyl, (6-10C)aryl(1-4C)alkyl, (3-9C)heteroaryl(1-4C)alkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, R8,R9-aminocarbonyl(1-4C)alkyl, R8,R9-amino(1-4C)alkyl, R8-oxycarbonyl(1-4C)alkyl, R8-oxy(1-4C)alkyl, R8-carbonyl(1-4C)alkyl or (6-10C)aryl; R7is H, (1-4C)alkyl, (1-4C)alkoxy, halogen, trifluoromethyl, cyano, nitro hydroxyl; and R8and/or R9is H, (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, (6-10C)aryl, (3-9C)heteroaryl, (6-10C)aryl(1-4C)alkyl, (3-9C)heteroaryl(1-4C)alkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, (1-4C)(di)alkylamino(1-4C)alkyl, (1-4C)alkoxy(1-4C)alkyl, (1-4C)alkylthio(1-4C)alkyl, (1-4C)alkylcarbonylamino(1-4C)alkyl, (1-4C)alkoxycarbonyl(1-4C)alkyl, (1-4C)alkoxycarbonylamino(1-4C)alkyl, (3-6C)cycloalkyl, (2-6C)heterocycloylkyl, or R8and R9may be joined in a (2-6C)heterocycloalkyl ring. The present invention also relates to pharmaceutical compositions comprising said derivatives and the use of these derivatives to control fertility.

REFERENCES:
patent: 2686182 (1954-08-01), Hopff et al.
patent: 6200963 (2001-03-01), Wrobel et al.
patent: 2004/0236109 (2004-11-01), Van Straten et al.
patent: 2006/0142334 (2006-06-01), Timmers
patent: 2006/0167047 (2006-07-01), Timmers et al.
patent: 0303306 (1989-02-01), None
patent: WO 96/19458 (1996-06-01), None
patent: 0008015 (2000-02-01), None
Chemical Abstracts, vol. 79, No. 9, Sep. 3, 1973, Columbux, Ohio, US; abstract No. 53152; Lugovik, B. A. et al: “Structure of compounds obtained from the interaction of 1, 2-dihydroquinolines with alkylbenzenes”.
Chemical Abstracts, vol. 77, No. 25, Dec. 18, 1972, Columbus, Ohio, US: abstract No. 164415, Lugovik, B.A.et al: “Reaction of 1, 2-dihydroqunolines with benzene and halobenzenes”.
Chemical Abstracts,. vol. 105, No. 7, Aug. 18, 1986, Columbus, Ohio, US; abstract No. 56990, , Shmyreva, ZH. V. et al: “Modification of anion exchanger Fuolite A 368 PR for the covalent immobilization of glucoamylase”.
Chemical Abstracts, “Ambinter-Screening Collection”, May 31, 2001.
Chemical Abstracts, Columbus Ohio, “VITAS-M Screening Collection”, Mar. 22, 2001.
CAS 327981-38-4.
CAS 360760-14-1.
CAS 299418-67-0.
CAS 299970-20-0.
Lugovik et al., “Reactions of 1,2-Dihydroxyquinolines IV. Reaction of 2,2,4-Trimethyl-1,2-Dihydroxyquinolines with Cyclohexane,” Khimiya geterotsiklicheskikh soedinenii 7 (1972) 977-980 (English-language translation attached).
Knoevenagel, E., “Information on the Ketone Anils, I: Preparation of Aliphatic Ketone Anils and Alkaline Hydrolysis of Ketone Anil Iodoalkylates,”Ber. Dtsch. Chem. Gesellschaft 54(1921) 1722-1730 (English-language translation attached).
International Search Report dated Oct. 7, 2002 and Written Opinion dated Apr. 4, 2003, which was issued during the prosecution of International Application No. PCT/EP02/07053, which corresponds to the present application.
International Search Report dated Jun. 30, 2004 and Int'l Preliminary Examination Report dated Sep. 23, 2004, which was issued during the prosecution of International Application No. PCT/EP03/51024, which corresponds to U.S. Appl. No. 10/540,335.
International Search Report dated Jun. 14, 2004 and Int'l Preliminary Examination Report dated Aug. 18, 2004, which was issued during the prosecution of International Application No. PCT/EP03/51025, which corresponds to U.S. Appl. No. 10/540,336.
Dorwald, F., “Side Reactions in Organic Synthesis”, Wiley-VCH, Weinheim p. IX of Preface, pp. 1-15 (2005).
Guo, T., “Small molecule agonists and antagonists for the LH and FSH receptors”, Expert Opinion on Therapeutic Patents, vol. 15, No. 11, pp. 1555-1564 (2005).
Jones, G., “The Chemistry of Heterocyclic Compounds: Quinolines Part 1”, John Wiley & Sons, New York, p. 104-117 (1977).
Kenakin, T., “The ligand paradox between affinity and efficacy: can you be there and not make a difference?” TRENDS in Pharmacological Sciences, vol. 23, No. 6, pp. 275-280 (2002).
Rao, A.J., “Is there a role for contraceptive vaccines in fertility control?”, Journal of Bioscience, vol. 26, No. 4, Suppl., pp. 425-427 (2001).
Sairam, M. R., et al., “The Role of Follicle-Stimulating Hormone in Spermatogensis: Lessons from Knockout Animal Models”,Archives of Medical Research, vol. 32, pp. 601-608 (2001).
Theoclitou, et al., “Novel facile synthesis of 2,2,4 substituted 1,2-dihydroquinolines via a modified Skraup reaction”,Tetrahedron Letters, 43, pp. 3907-3910 (2002).
Ulloa-Aguirre, A., et al., “Role of the intracellular domains of the human FSH receptor in GαSprotein coupling and receptor expression”,Molecular and Cellular Endocrinology, pp. 260-262, 153-162 (2007).
Van Straten, et al., “Identification of Substituted 6-Amino-4-phenyltetrahydroquinoline Derivatives: Potent Antagonists for the Follicle-Stimulating Hormone Receptor”,Journal of Medicinal Chemistry, vol. 48, No. 6, pp. 1697-1700 (2005).
Notice of Allowance dated Aug. 14, 2009 for U.S. Appl. No. 10/540,335, which is related to the present application.
Non-Final Office Action dated Dec. 5, 2008 for U.S. Appl. No. 10/540,335, which is related to the present application.
Non-Final Office Action dated Jul. 11, 2007 for U.S. Appl. No. 10/540,336, which is related to the present application.
RN 339273-93-7 Registry, Jun. 4, 2001.
RN 91147-49-8 Registry, Nov. 16, 1984.
RN 332904-33-3 Registry, Apr. 26, 2001.
Atanes et. al., “Synthesis of 7-Substituted Dehydronoraporphines, with some Biogenetic Considerations,”Tetrahedron50 (1994) 11257-11266.
Atkins et al, “Substituted Coumarins and Azacoumarins. Synthesis and Fluorescent Properties,”J. Org. Chem. 43 (1978) 1975-1980.
Barmettler et. al., “Acid-Catalyzed [3,3]-Sigmatropic Rearrangements ofN-Propargylanilines,”Helv. Chim. Acta73 (1990) 1515-1573.
Bonnat et. al., “The Solid Phase Synthesis of a Guanidinium Based ‘Tweezer’ Receptor,”Tetrahedron Lett. 37 (1996) 5409-5412.
Bouyssou et. al., “Synthesis of 7- and 5,7-Substituted-6-fluoro-2-methyl-1,2,3,4-tetrahydroquinolines: Convenient Precursors of Quinolone Antibacterial Agents,”J. Heterocycl. Chem. 29 (1992) 895-898.
Cerfontain et al., “The Positional Reactivity Order in the Sulfur Trioxide Sulfonation of Benzene and Naphthalene Derivatives Containing an Electron-Withdrawing Substituent,”Recl. Trav. Chim. Pays-Bas, 113 (1994) 403-410.
Coppock, A., “New Synthesis of Aryl Esters of Aromatic Acids,”J. Org. Chem. 22 (1957) 325-326.
Devroey et. al. “Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH,” Lancet 339 (1992) 1170-1171.
Dorrington et al, “Effects of FSH on Gonadal Functions,”Recent Prog. Horm. Res. 35(1979) 301-342.
Edwards et. al., “5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as Potent, Orally Active, Nonsteroidal Progesterone Receptor Agonists: The Effect of D-Ring Substituents,”J. Med. Chem. 41 (1998) 303-310.
Edwards et. al., “Lewis-acid Catalyzed Reaction of 2-1 sopropenylaniline with Ketones: Improved Synthesis of 2,2,4-Trisubstituted 1,2-Dihydroquinolines,”Tetrahedron Lett. 39 (1998) 5139

Affiliated with

Also associated with

Rating

Tetrahydroquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydroquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroquinoline derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4308676